By the Top Tier Newswire AI Desk · August 10, 2026 at 10:06 AM ET · reviewed against 6 wire stories
RADNET INC (RDNT) is up +7.14% in the latest session. Our newswire has captured 6 stories on RDNT across 5 sources in the last 36 hours, with AI sentiment reading bullish (avg 66/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
RDNT stock is up 7.14% to $77.56 as of the latest trade, driven by RadNet's record-breaking second quarter results and upgraded 2026 guidance. The company reported a 25% year-over-year revenue increase to $622.7 million and a non-GAAP EPS of $0.29, exceeding consensus estimates. The Digital Health segment also showed strong growth, with surging Advanced Recurring Revenue (ARR), contributing to the revised 2026 financial outlook.
What Happened
RadNet delivered a record-breaking quarter, driven by a 25% revenue jump and robust advanced imaging demand. The company's Q2 results, reported on August 10, 2026, included a non-GAAP EPS of $0.29, surpassing the $0.20 estimate. The company also announced an upward revision of its 2026 financial guidance, reflecting confidence in continued momentum. The Digital Health segment, which includes the DeepHealth unit, saw significant growth, with AI-powered breast ultrasound tools receiving FDA 510(k) clearance and expected to roll out across the network by year-end. The SEC 8-K filing on the same day confirmed the results and included updated financial statements.
What The Data Shows
The stock opened at $74.87, a 3.4% gap up from the prior close, and reached an intraday high of $78.34 at 10:00 AM ET before pulling back to $69.81 at 9:35 AM ET. The session closed near the high at $77.45, with a volume of 0.2 million shares, which is 0.2 times the 3-month daily average. RadNet's fundamentals show a market cap of $5.4 billion, with a trailing 12-month revenue growth of 14.7% and a net margin of -0.7%. The stock is currently trading within its 52-week range of $50.76 to $85.84. The company remains unprofitable with a trailing 12-month EPS of -0.19.
What To Watch
RadNet has no scheduled earnings date in the immediate future. Investors should monitor the breadth of coverage and any follow-up analyst commentary on the company's upgraded guidance and Digital Health segment performance.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
RDNT · today's session (5-min) · +6.22% vs prior close · updated 3:17 PM ETAI sentiment, last 36h · averaged over 6 stories · 66/100 bullish
The headlines behind the move
Story flow · 6 stories on the wire, last 36h · hover or tap a dot for the headline
9h agoMarketChameleonBULLISH 73Earnings
RadNet Raises the Bar: Record Revenue, Surging Digital Health Growth, and Upgraded 2026 Outlook
August 10, 2026
RadNet delivered a record-breaking quarter, driven by a 25% revenue jump, surging Digital Health ARR, and robust advanced imaging demand. The company also revised its 2026 financial guidance higher, signaling confidence in its growth trajectory.
11h agoSEC 8-KNEUTRAL 50General
RadNet, Inc. (RDNT) files 8-K
Filed: 2026-08-10 AccNo: 0001683168-26-006125 Size: 466 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
16h agoSeeking AlphaBULLISH 63Earnings
RadNet Non-GAAP EPS of $0.29, revenue of $622.7M; updates FY2026 outlook
RadNet press release (RDNT): Q2 Non-GAAP EPS of $0.29. Revenue of $622.7M (+25.0% Y/Y).
21h agoThe FlyBULLISH 71Earnings
RadNet reports Q2 adjusted EPS 29c, consensus 20c
1d agoSeeking AlphaBULLISH 68Earnings
RadNet beats Q2 estimates, raises outlook as imaging demand surges
RadNet (RDNT) beats Q2 revenue and EPS as MRI/CT/PET volumes surge and DeepHealth Digital Health ARR jumps.
1d agoBusiness InsiderBULLISH 73Earnings
RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges
Total Company Revenue increased 25.0% to a quarterly record of $622.7 million in the second quarter of 2026 from $498.2 million in the second quarter of 2025 Revenue from the Digital Health reportable segment (inclusive...
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →